Josh Welsh

Josh Welsh

Josh Welsh is a senior journalist in the Wealth vertical for Key Media, where he covers the people, firms, and trends in the benefits and pensions space. As lead reporter for Benefits and Pensions Monitor (BPM), he reports on institutional investing, pension governance, retirement policy, as well as employer-sponsored benefits plans. He has also contributed to BPM's sister US publication InvestmentNews.

His reporting draws on direct conversations with industry experts, CIOs, plan sponsors and portfolio managers, translating complex developments in capital markets, pension plans and regulation into clear, accurate coverage for industry decision-makers. He adheres to Key Media's editorial standards on sourcing, verification, and disclosure, and is committed to accuracy, balance, and accountability to readers.

Josh is a Humber Polytechnic graduate, with a bachelor's in journalism and a diploma in screen acting. Outside the newsroom, he's a member of the historic Arts and Letters Club of Toronto, an avid filmgoer, and continues to pursue his passion for acting.

Email | LinkedIn 

Pension plan design can fix retirement expectations, says CAAT

CAAT Pension Plan’s Jillian Kennedy and Anthony Damtsis explain why Canadians underestimate retirement savings, what plan designs are currently lacking

Pension plan design can fix retirement expectations, says CAAT

Employers can break AI guilt through clarity and training: HR leaders

Despite AI anxiety growing among employees, plan sponsors at OTIP and BC Hydro say transparency, addressing uncertainty is the fix

Employers can break AI guilt through clarity and training: HR leaders

Why employers can't ignore eco-anxiety in the workplace

Beneva urges employers to act on eco-anxiety in the workplace after 1 in 5 report climate-related stress impacts workplace productivity

Why employers can't ignore eco-anxiety in the workplace

Novo Nordisk sues Eli Lilly over GLP-1 advertising claims

Novo Nordisk alleges their rival's advertising campaigns for its drugs are designed to mislead consumers about their superior efficacy

Novo Nordisk sues Eli Lilly over GLP-1 advertising claims

Emerging markets' AI story is 'underestimated’ as AI spending pours into EM Asia

EM experts share why Taiwan and South Korea now dominate the EM index as AI semiconductor capex reshapes opportunities for institutional investors

Emerging markets' AI story is 'underestimated’ as AI spending pours into EM Asia

Pension investors are overthinking duration risk: FTSE Russell

FTSE Russell’s Robin Marshall and Indrani De outline what treasury yields and duration risk tell institutional investors about future returns

Pension investors are overthinking duration risk: FTSE Russell

Why funding policies are the anchor DB plan sponsors need now

DB plan surpluses demand governance, not improvisation, says Normandin Beaudry’s Claude St-Laurent and Isabelle Clément

Why funding policies are the anchor DB plan sponsors need now

AI disruption may break K-shaped economy keeping markets afloat: CIO

Sun Life’s Chhad Aul explains how AI could undermine the wealth effect propping up markets and why this matters for plan sponsors

AI disruption may break K-shaped economy keeping markets afloat: CIO

DC plans aren't ready for decumulation: Sun Life’s Meloche

Meloche argues retirement income and decumulation solutions need scale, sponsor readiness, and advisor education before Canadian DC plans can adopt them

DC plans aren't ready for decumulation: Sun Life’s Meloche

Generic semaglutide sparks fresh debate over substitution

Medavie Blue Cross’ Marie-Hélène Dugal explains how generic semaglutide is reigniting mandatory generic substitution in plans

Generic semaglutide sparks fresh debate over substitution